Intravenously injected lidocaine or magnesium improves the quality of early recovery after laparoscopic cholecystectomy: A randomised controlled trial.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The researchers aimed to observe the effects of lidocaine or magnesium on the quality of recovery (QoR) after laparoscopic cholecystectomy.

Why It Was Studied

Previous data show that lidocaine or magnesium has unique characteristics of stress inhibition and antiinflammation.

The study was registered in the Chinese Clinical Trials Register (ChiCTR1800019092) https://www.chictr.org.cn.

Who Took Part

One hundred and fourteen patients scheduled for laparoscopic cholecystectomy.

The enrolled patients were randomly divided into three groups.

How the Study Was Run

In design terms this was a randomized and double-blind study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

Single-centre, prospective, randomised, double-blind study.

The Affiliated Hospital of Xuzhou Medical University from March 2019 to October 2019.

What Was Measured

PubMed files the paper under topics including Cholecystectomy, Laparoscopic, Lidocaine, Magnesium, Postoperative Pain and Propofol.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2021 (European journal of anaesthesiology), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.